Mrinal M. Patnaik, Physician Scientist, Department of Internal Medicine at Mayo Clinic, Minnesota, shared a recent article by him and colleagues on X:
“Single-cell multiomics reveal divergent effects of DNMT3A- and TET2-mutant clonal hematopoiesis in inflammatory response.
Why does DNMT3A CH increase mortality in the context of COVID-19 and VEXAS multiomics?”
Authors: Wazim Mohammed Ismail, Jenna A. Fernandez, Moritz Binder, Terra L. Lasho, Minsuk Kim, Susan M. Geyer, Amelia Mazzone, Christy M. Finke, Abhishek A. Mangaonkar, Jeong-Heon Lee, Liguo Wang, Kwan Hyun Kim, Vernadette A. Simon, Fariborz Rakhshan Rohakthar, Amik Munankarmy, Seul Kee Byeon, Susan M. Schwager, Jonathan J. Harrington, Melissa R. Snyder, Keith D. Robertson, Akhilesh Pandey, Eric D. Wieben, Nicholas Chia, Alexandre Gaspar-Maia and Mrinal M. Patnaik
More posts featuring Mrinal M. Patnaik.